[小细胞肺癌的治疗]
[Treatment of small cell lung cancer].
作者信息
Negoro Shunichi
机构信息
Dept. of Thoracic Oncology, Hyogo Medical Center for Adults, Akashi City, Japan.
出版信息
Gan To Kagaku Ryoho. 2005 Jun;32(6):777-82.
PMID:15984515
Abstract
The treatment of choice for limited small-cell lung cancer (SCLC) is platinum-based chemotherapy combined with early, concurrent thoracic radiotherapy with a hyperfractionated regimen. The standard chemotherapy for extensive SCLC in Japan is the combination of irinotecan and cisplatin. There are expectations for new and effective molecular-target-based drugs for SCLC.
摘要
局限性小细胞肺癌（SCLC）的首选治疗方法是铂类化疗联合早期同步超分割方案的胸部放疗。在日本，广泛期SCLC的标准化疗方案是伊立替康和顺铂联合使用。人们期待有新的、有效的基于分子靶点的药物用于治疗SCLC。
相似文献
1
[Treatment of small cell lung cancer].
Gan To Kagaku Ryoho. 2005 Jun;32(6):777-82.
2
Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.
Clin Cancer Res. 2005 Aug 1;11(15):5534-8. doi: 10.1158/1078-0432.CCR-04-1771.
3
Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902.
J Clin Oncol. 2006 Nov 20;24(33):5247-52. doi: 10.1200/JCO.2006.07.1605.
4
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
J Clin Oncol. 2005 Aug 1;23(22):4991-8. doi: 10.1200/JCO.2005.00.414. Epub 2005 Jun 6.
5
[Lung cancer with bone metastasis].
Gan To Kagaku Ryoho. 2006 Aug;33(8):1049-53.
6
Small-cell lung cancer: current therapy and novel agents.
Oncology (Williston Park). 2005 Jan;19(1):47-52; discussion 52, 54-8.
7
Irinotecan and cisplatin with concurrent thoracic radiotherapy in a once-every-three-weeks schedule in patients with limited-disease small-cell lung cancer: a phase I study.
Lung Cancer. 2008 Jul;61(1):123-8. doi: 10.1016/j.lungcan.2007.11.010. Epub 2008 Jan 7.
8
Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
Clin Lung Cancer. 2003 Jul;5(1):40-5. doi: 10.3816/CLC.2003.n.020.
9
Combined chemoradiation therapy for limited-stage small-cell lung cancer.
Oncology (Williston Park). 1999 Oct;13(10 Suppl 5):107-15.
10
Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group.
J Clin Oncol. 1998 Mar;16(3):1068-74. doi: 10.1200/JCO.1998.16.3.1068.
Zotero 插件